Chee Kong Choo - 18 Mar 2026 Form 3 Insider Report for CytoMed Therapeutics Ltd (GDTC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
15 May 2026, 09:00:32 UTC
Prior SEC filing
14 Apr 2023
Next SEC filing
15 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Chee Kong Choo

Key filing fact

Chee Kong Choo filed Form 3 for CytoMed Therapeutics Ltd (GDTC) on 15 May 2026.

Key facts

  • This page summarizes Chee Kong Choo's Form 3 filing for CytoMed Therapeutics Ltd (GDTC).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 15 May 2026, 09:00.

Change

  • Previous filing in this sequence was filed on 14 Apr 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001970632 Primary reporting owner

Choo Chee Kong

Relationship
Director, 10%+ Owner
Address
C/O CYTOMED THERAPEUTICS LIMITED, 1 COMMONWEALTH LANE #08-22, SINGAPORE, SINGAPORE
Signature
/s/ Chee Kong Choo
Signature date
15 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDTC holding

Ordinary Shares, no par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,075,310
Date
18 Mar 2026
Ownership
Via 55% ownership of Glorious Finance Limited
Footnotes
F1
GDTC holding

Ordinary Shares, no par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
194,112
Date
18 Mar 2026
Ownership
Via 100% ownership of EP Capital Inc.
Footnotes
F2
GDTC holding

Ordinary Shares, no par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
318,324
Date
18 Mar 2026
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

3,773,291 Ordinary Shares is presently held by Glorious Finance Limited ("Glorious Finance"). CHOO Chee Kong ("Mr. Choo") owns 55.0% of shares in Glorious Finance and has beneficial ownership of 2,075,310 Ordinary Shares. Mr. Choo disclaims beneficial ownership of 1,697,981 Ordinary Shares held by Glorious Finance to the extent that he does not have an economic interest therein;

Footnote F2

194,112 Ordinary Shares held by EP Capital Inc. ("EP Capital"). Mr. Choo is deemed to beneficially own the 194,112 Ordinary Shares held by EP Capital, and

Footnote F3

318,324 Ordinary Shares held directly by Mr. Choo.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .